| Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients JA Lednicky, M Lauzardo, ZH Fan, A Jutla, TB Tilly, M Gangwar, ... International Journal of Infectious Diseases 100, 476-482, 2020 | 738 | 2020 |
| Early convalescent plasma for high-risk outpatients with Covid-19 FK Korley, V Durkalski-Mauldin, SD Yeatts, K Schulman, RD Davenport, ... New England Journal of Medicine 385 (21), 1951-1960, 2021 | 229 | 2021 |
| Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program. Transfer from high-acuity long-term care facilities is associated with carriage of Klebsiella … K Prabaker, MY Lin, M McNally, K Cherabuddi, S Ahmed, A Norris, ... Infect Control Hosp Epidemiol 33 (12), 1193-1199, 2012 | 125* | 2012 |
| Vaccine enthusiasm and hesitancy in cancer patients and the impact of a webinar AH Kelkar, JA Blake, K Cherabuddi, H Cornett, BL McKee, CR Cogle Healthcare 9 (3), 351, 2021 | 72 | 2021 |
| India's COVID-19 crisis: a call for international action K Kuppalli, P Gala, K Cherabuddi, SP Kalantri, M Mohanan, B Mukherjee, ... The Lancet 397 (10290), 2132-2135, 2021 | 63 | 2021 |
| Coinfection with Zika and dengue-2 viruses in a traveler returning from Haiti, 2016: clinical presentation and genetic analysis NM Iovine, J Lednicky, K Cherabuddi, H Crooke, SK White, JC Loeb, ... Clinical Infectious Diseases, ciw667, 2016 | 55 | 2016 |
| Early therapeutic monitoring of β-lactams and associated therapy outcomes in critically ill patients MH Al-Shaer, E Rubido, K Cherabuddi, V Venugopalan, K Klinker, ... Journal of Antimicrobial Chemotherapy 75 (12), 3644-3651, 2020 | 51 | 2020 |
| Chloroquine and hydroxychloroquine in the context of COVID-19. Drugs Context. 2020; 9: 1-8 AM Shukla, LK Archibald, A Wagle Shukla, HJ Mehta, K Cherabuddi Drugs Context, 2020 | 51 | 2020 |
| Efficacy of losartan in hospitalized patients with COVID-19–induced lung injury: a randomized clinical trial MA Puskarich, NE Ingraham, LH Merck, BE Driver, DA Wacker, LP Black, ... JAMA network open 5 (3), e222735-e222735, 2022 | 50 | 2022 |
| Ampicillin for the treatment of complicated urinary tract infections caused by vancomycin–resistant Enterococcus spp (VRE): a single-center university hospital experience KJ Shah, K Cherabuddi, J Shultz, S Borgert, R Ramphal, KP Klinker International Journal of Antimicrobial Agents 51 (1), 57-61, 2018 | 42 | 2018 |
| Potent in vitro and in vivo antifungal activity of a small molecule host defense peptide mimic through a membrane-active mechanism LP Menzel, HM Chowdhury, JA Masso-Silva, W Ruddick, K Falkovsky, ... Scientific Reports 7 (1), 4353, 2017 | 36 | 2017 |
| Clinical and microbiologic outcomes in patients with monomicrobial Stenotrophomonas maltophilia infections C Nys, K Cherabuddi, V Venugopalan, KP Klinker Antimicrobial Agents and Chemotherapy 63 (11), 10.1128/aac. 00788-19, 2019 | 35 | 2019 |
| Zika and Chikungunya virus co-infection in a traveller returning from Colombia, 2016: virus isolation and genetic analysis K Cherabuddi, NM Iovine, K Shah, SK White, T Paisie, M Salemi, ... JMM case reports 3 (6), e005072, 2016 | 32 | 2016 |
| Population pharmacokinetics and target attainment of cefepime in critically ill patients and guidance for initial dosing MH Al-Shaer, MN Neely, J Liu, K Cherabuddi, V Venugopalan, ... Antimicrobial agents and chemotherapy 64 (9), 10.1128/aac. 00745-20, 2020 | 29 | 2020 |
| Antimicrobial stewardship training for infectious diseases fellows: program directors identify a curriculum need VP Luther, R Shnekendorf, LM Abbo, S Advani, WS Armstrong, ... Clinical infectious diseases 67 (8), 1285-1287, 2018 | 28 | 2018 |
| Use of novel strategies to develop guidelines for management of pyogenic osteomyelitis in adults: a WikiGuidelines group consensus statement B Spellberg, G Aggrey, MB Brennan, B Footer, G Forrest, F Hamilton, ... JAMA network open 5 (5), e2211321-e2211321, 2022 | 26 | 2022 |
| Performance of a semiquantitative multiplex bacterial and viral PCR panel compared with standard microbiological laboratory results: 396 patients studied with the BioFire … KH Rand, SG Beal, K Cherabuddi, B Couturier, B Lingenfelter, ... Open Forum Infectious Diseases 8 (1), ofaa560, 2021 | 26 | 2021 |
| Keystone virus isolated from a Florida teenager with rash and subjective fever: another endemic arbovirus in the southeastern United States? JA Lednicky, SK White, CJ Stephenson, K Cherabuddi, JC Loeb, ... Clinical Infectious Diseases 68 (1), 143-145, 2019 | 23 | 2019 |
| Applying athletic principles to medical rounds to improve teaching and patient care F Southwick, M Lewis, D Treloar, K Cherabuddi, N Radhakrishnan, ... Academic Medicine 89 (7), 1018-1023, 2014 | 22 | 2014 |
| Angiotensin Receptor Blocker Based Lung Protective Strategies for Inpatients With COVID-19 (ALPS-IP) Investigators. Efficacy of losartan in hospitalized patients with COVID-19 … MA Puskarich, NE Ingraham, LH Merck, BE Driver, DA Wacker, LP Black, ... JAMA Netw Open 5 (3), e222735, 2022 | 20 | 2022 |
